(Q74202142)

English

Higher doses of alpha-interferon do not increase the activity of the weekly cisplatin-interferon combination in advanced malignant mesothelioma

scientific article published on 01 October 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470855%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Higher doses of alpha-interferon do not increase the activity of the weekly cisplatin-interferon combination in advanced malignant mesothelioma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470855%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

L Trandafir

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470855%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

P Ruffié

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470855%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

C Borel

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470855%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

I Monnet

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470855%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

P Soulié

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470855%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

D Adams

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470855%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

E Cvitkovic

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470855%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J P Armand

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470855%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 October 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470855%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470855%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

33

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470855%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470855%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1900-1902

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470855%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Combined systemic chemoimmunotherapy in advanced diffuse malignant mesothelioma. Report of a phase I-II study of weekly cisplatin/interferon alfa-2a

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900263-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I trial of intermittent high-dose alpha-interferon and dexamethasone in metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900263-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Potentiation of cisplatin by alpha-interferon in advanced non-small cell lung cancer (NSCLC): a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900263-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of continuous subcutaneous interferon-alfa combined with cisplatin in advanced malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900263-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of chemotherapy and recombinant alpha-interferon in advanced non-small cell lung cancer. Multicentric Randomized FONICAP Trial Report. The Italian Lung Cancer Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900263-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(97)00263-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470855%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470855%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74202142&oldid=2116687633"